Edition:
United States

Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

513.85INR
22 Sep 2017
Change (% chg)

Rs-5.80 (-1.12%)
Prev Close
Rs519.65
Open
Rs518.95
Day's High
Rs528.50
Day's Low
Rs508.70
Volume
7,990,848
Avg. Vol
5,647,133
52-wk High
Rs790.75
52-wk Low
Rs432.70

Chart for

About

Sun Pharmaceutical Industries Limited is a pharmaceuticals company. The Company's business segments include US Business, Indian Branded Generics Business, Emerging Markets, Global Consumer Healthcare Business and Active Pharmaceutical Ingredients (API). Its Rest of World segment includes Western Europe, Canada, Australia, New... (more)

Overall

Beta: 0.07
Market Cap(Mil.): Rs1,232,884.00
Shares Outstanding(Mil.): 2,399.31
Dividend: 3.50
Yield (%): 0.68

Financials

  Industry Sector
P/E (TTM): -- 31.67 16.08
EPS (TTM): -- -- --
ROI: -- 15.12 14.60
ROE: -- 16.35 14.03

BRIEF-Sun Pharmaceutical Industries says unit gets U.S. FDA nod for new label for odomzo (sonidegib)

* Says one of co's units received approval from U.S. FDA for new label for odomzo (sonidegib) Source text - http://bit.ly/2f8WIsa Further company coverage:

Sep 19 2017

BRIEF-Sun Pharmaceutical Industries seeks shareholders' nod for re-appointment of Dilip S. Shanghvi as MD

* Seeks shareholders' nod for re-appointment of dilip s. Shanghvi as managing director

Aug 31 2017

UPDATE 2-India's Sun Pharma reports Q1 loss as generics business suffers

* Expects profit margin to improve in second-half of 2018 (Adds Managing Director comments from conference call)

Aug 11 2017

BRIEF-Sun Pharma says co on track to achieve $300 mln synergies from Ranbaxy deal

* MD Dilip Shanghvi says on track to achieve $300 million synergies from Ranbaxy deal

Aug 11 2017

BRIEF-Sun Pharmaceutical Industries posts June-qtr consol loss

* June quarter consol net loss 4.25 billion rupees versus profit 20.34 billion rupees last year

Aug 11 2017

Indian shrs fall for 3rd day; US-N.Korea tensions spook investors

Aug 9 Indian shares fell for a third consecutive session on Wednesday, dragged down by financial and healthcare stocks, as escalating tensions on the Korean peninsula hit regional markets.

Aug 09 2017

BRIEF-Sun Pharmaceutical Industries says unit to acquire 15.91 pct diluted stake of Krystal Biotech

* Unit agreed to acquire by way of allotment 203,135 series A preferred stock of Krystal Biotech Inc for $7 million Source text: (http://bit.ly/2vi3zH0) Further company coverage:

Aug 08 2017

BRIEF-Sun Pharmaceutical Industries raises stake in Zenotech

* Raises stake in Zenotech from 46.85 percent of pre rights issue capital to 57.56 percent of post rights issue capital Source text - http://bit.ly/2u1jh7f Further company coverage:

Jul 27 2017

BRIEF-Sun Pharma Advanced Research Co seeks members' nod to approve transactions with Sun Pharmaceutical Industries Inc

* Seeks members' nod to approve transactions with Sun Pharmaceutical Industries Inc, USA

Jul 10 2017

BRIEF-Sun Pharmaceutical Industries announces manufacturing tie-up with Samsung Biologics

* Strategic manufacturing tie-up with Samsung Biologics for Tildrakizumab

Jul 03 2017

Earnings vs. Estimates